Avails Medical is at the forefront of addressing the critical issue of antimicrobial resistance through its innovative rapid antimicrobial susceptibility testing (AST) technology. Their patented electronic biosensor platforms are designed to significantly reduce the time required to obtain actionable results from diagnostic tests, which is crucial for effective treatment of life-threatening infections. By detecting metabolic byproducts from microorganisms, these biosensors enable precise pathogen quantification directly from positive blood cultures. This rapid response capability allows healthcare teams to make informed decisions quickly, ultimately improving patient outcomes and reducing unnecessary hospital stays.

The technology developed by Avails Medical is characterized by its compact design, adaptability, and user-friendly interface, making it suitable for a wide range of healthcare settings. Their products, such as the eQUANT platform, are not only cost-effective but also ensure that even smaller hospitals can access advanced diagnostic solutions. By streamlining the workflow in clinical microbiology laboratories, Avails Medical's biosensor technology addresses the urgent need for faster diagnostics, thereby contributing to the fight against the growing challenge of antibiotic resistance.

United States

Avails Medical, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health-care associated infections.

Avails Medical

Company Details